The Guardian view on gene-edited humans: darker uses must be acknowledged alongside medical ones | Editorial
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Two new studies used base editing — a next-generation Crispr tool — on human embryos; the research is legal in the UK and US provided embryos are destroyed within 14 days.
- 70 countries, including the UK, have laws against human germline editing, though most are framed around safety rather than broader ethical objections.
- The Nuffield Council on Bioethics and the US National Academies of Sciences, Engineering, and Medicine both hold human germline editing is not ethically unacceptable in itself, and bioethicist R Alta Charo argues each advance chips away at safety objections.
- Dieter Egli, lead author of one study, said the technology is not yet ready for the clinic but advances would "guide responsible research to achieve its ultimate safe and effective use."
- Ipsos polling for the Progress Educational Trust found majorities in the UK, Spain, and the Netherlands support gene editing for life-threatening conditions like cystic fibrosis, with plurality support for manageable conditions like asthma.
- In the UK, where donor selection in IVF is illegal, some couples already use companies abroad to screen for desirable traits, and in the US, IVF companies are already collaborating with labs doing base-editing research, per the editorial.
Why it matters: With 70 countries already banning germline editing on safety grounds, and with US IVF companies already partnering with base-editing labs while UK couples go abroad for trait screening, the regulatory gap between sanctioned medical research and unregulated non-medical use is closing before any public policy debate has occurred.
